Genotyping of RNF213 p.Asn2327Asp in 2,502 MS patients and 1,075 healthy controls from Canada identified this variant in eight additional familial probands and four patients without a family history of MS, resulting in a MAF of 0.26%. The gene discussed is RNF213; the disease is myeloid sarcoma.